Ottobock IPO revisited: €66 offer price and a €72 Frankfurt debut
A look back at Ottobock’s October 2025 listing, including the difference between its €807.6 million placement and the capital raised for the company.
This retrospective covers Ottobock’s completed October 2025 IPO. The medical technology company began trading in Frankfurt’s Prime Standard on 9 October 2025. The exchange recorded an opening price of €72, compared with the €66 offer price. Its businesses include prosthetics, orthotics and exoskeletons. These are historical transaction figures, rather than a current share quotation. Deutsche Börse’s listing announcement.
The deal’s structure matters. Ottobock’s pricing announcement described 12,236,173 shares including the overallotment, with total placement volume of approximately €807.6 million assuming full exercise of the greenshoe. That implied an equity valuation of about €4.2 billion and expected free float of 19.12%. Most shares came from an existing shareholder. The entire placement amount therefore did not become cash available to Ottobock. Final pricing announcement.
In its announcement after the debut, Ottobock put proceeds from newly issued shares at approximately €100 million. Management said the capital would support future technologies and expansion of its international patient care network. That distinction helps explain how a sizeable shareholder sale can accompany a more modest capital increase. Ottobock’s debut release.
For readers tracking completed offerings, the reference points are the listing date, offer price, opening trade and allocation of proceeds. Ottobock’s investor page identifies the share with ticker OBCK and ISIN DE000BCK2223, making it easier to distinguish the listed security from older reports about a possible flotation. Official share information.